Want to join the conversation?
$AGN said its top global products, comprising more than 75% of total branded revenue, grew 13%, excluding the impact of currency & Namenda IR. In CNS, the company delivered 21% growth, with Botox, Namenda XR and Vraylar being key growth products. In Aesthetics, sales rose by 7%, with Botox, Fillers and Kybella being strong drivers for the quarter.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.